Regentis Biomaterials Ltd.
RGNT
New York Stock Exchange American4.05
USD
+0.02
- -
Total Valuation
Regentis Biomaterials Ltd. carries a market capitalization of 15.95M, placing it among publicly traded companies globally.
| Market Cap | 15.95M |
| Enterprise Value | N/A |
Stock Price Statistics
Regentis Biomaterials Ltd.'s stock has declined approximately -46% over the past 52 weeks. The 50-day moving average sits at 2.85, while the 200-day moving average is 4.21.
| Beta (5Y) | N/A |
| 52-Week Price Change | -46% |
| 50-Day Moving Average | 2.85 |
| 200-Day Moving Average | 4.21 |
| Average Volume (20 Days) | N/A |